SonoScape Medical Corp. (SHE:300633)
China flag China · Delayed Price · Currency is CNY
26.87
-0.76 (-2.75%)
Apr 24, 2026, 3:04 PM CST

SonoScape Medical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
11,56311,35612,65620,37023,46012,833
Market Cap Growth
-10.47%-10.27%-37.87%-13.17%82.80%22.89%
Enterprise Value
10,20910,24011,21218,76122,08812,399
Last Close Price
26.8726.4229.3046.7654.0331.36
PE Ratio
58.4157.5688.8844.8263.4451.91
Forward PE
33.9533.1625.8734.5857.5350.58
PS Ratio
5.014.926.299.6113.318.88
PB Ratio
3.543.484.076.488.565.45
P/TBV Ratio
3.843.774.467.249.736.32
P/FCF Ratio
--126.8265.1982.9285.13
P/OCF Ratio
--41.2741.6249.5742.36
EV/Sales Ratio
4.424.435.578.8512.538.58
EV/EBITDA Ratio
48.5553.3366.8636.9561.9450.04
EV/EBIT Ratio
91.7592.03111.0540.9968.8157.35
EV/FCF Ratio
-53.62-112.3560.0478.0782.26
Debt / Equity Ratio
0.100.100.110.020.080.05
Debt / EBITDA Ratio
1.471.471.900.140.580.41
Debt / FCF Ratio
--3.560.230.770.74
Net Debt / Equity Ratio
-0.41-0.41-0.53-0.56-0.56-0.55
Net Debt / EBITDA Ratio
-7.05-7.05-9.87-3.45-4.31-5.26
Net Debt / FCF Ratio
7.117.11-16.58-5.61-5.43-8.65
Asset Turnover
0.530.530.500.580.540.55
Inventory Turnover
1.301.301.331.381.311.42
Quick Ratio
1.941.942.083.552.643.00
Current Ratio
2.762.762.754.623.363.84
Return on Equity (ROE)
6.19%6.19%4.55%15.44%14.52%13.36%
Return on Assets (ROA)
1.59%1.59%1.56%7.82%6.11%5.13%
Return on Invested Capital (ROIC)
5.69%6.62%7.09%33.84%27.59%21.64%
Return on Capital Employed (ROCE)
3.30%3.30%3.10%14.30%11.50%8.80%
Earnings Yield
1.71%1.74%1.13%2.23%1.58%1.93%
FCF Yield
-1.65%-1.68%0.79%1.53%1.21%1.18%
Dividend Yield
0.65%0.68%0.34%0.68%0.33%0.40%
Payout Ratio
23.94%23.94%101.36%18.20%15.62%2.24%
Buyback Yield / Dilution
0.61%0.61%0.30%-0.65%-7.83%-3.44%
Total Shareholder Return
1.26%1.29%0.64%0.04%-7.50%-3.04%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.